# Aurore Pharmaceuticals Private Limited (Unit I) - Inspection Records

Source: https://www.keypedia.com/companies/aurore-pharmaceuticals-private-limited-unit-i/324c0fea-91ef-4166-9a39-208a151fb12f

> Inspection records and compliance data for Aurore Pharmaceuticals Private Limited (Unit I) in Hyderabad, None. Access full analysis and detailed observations.

---

## Details

- Name: Aurore Pharmaceuticals Private Limited (Unit I)
- FEI Number: 3003937580
- City: Hyderabad
- State: None
- Country Name: India
- Address Line 1: Unit-I, Plot Nos. 35,36,38 to 40, 49 to 51, Phase IV, IDA,, Jeedimetla
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [483 - Aurore Pharmaceuticals Private Limited (Unit I) - 2024-05-31](https://www.keypedia.com/records/483/aurore-pharmaceuticals-private-limited-unit-i/45afdfde-b162-47e2-b510-3ca11a5fdc1a) — source: FDA, date: May 31, 2024
- [FDA Inspection 1240159 - Aurore Pharmaceuticals Private Limited (Unit I) - 2024-05-31](https://www.keypedia.com/records/fda_inspections/aurore-pharmaceuticals-private-limited-unit-i/068064fa-0020-4498-8f37-a3007bf80525) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 31, 2024
- [483 - Aurore Pharmaceuticals Private Limited (Unit I) - 2024-05-27](https://www.keypedia.com/records/483/aurore-pharmaceuticals-private-limited-unit-i/6a7c3efc-4945-4b60-ab7a-c603a0c3a683) — source: FDA, date: May 27, 2024
- [FDA Inspection 1059153 - Aurore Pharmaceuticals Private Limited (Unit I) - 2018-05-25](https://www.keypedia.com/records/fda_inspections/aurore-pharmaceuticals-private-limited-unit-i/6784c958-3441-4166-a5b1-13049f6436c3) — classification: No Action Indicated (NAI), source: FDA, date: May 25, 2018
- [FDA Inspection 872450 - Aurore Pharmaceuticals Private Limited (Unit I) - 2014-02-07](https://www.keypedia.com/records/fda_inspections/aurore-pharmaceuticals-private-limited-unit-i/bfc4b31f-7a38-49c4-9b6b-2fa123e1b54e) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2014
- [FDA Inspection 699241 - Aurore Pharmaceuticals Private Limited (Unit I) - 2010-10-29](https://www.keypedia.com/records/fda_inspections/aurore-pharmaceuticals-private-limited-unit-i/0ba713e7-b8b9-4fd6-ad2c-47cccc6206d9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 29, 2010

## Related Companies

- [Bioiberica, SAU](https://www.keypedia.com/companies/bioiberica-sau/3984e671-30b1-4c37-b603-0e20b5a76b7d)
- [NATCO Pharma Limited Chemical Division Chennai](https://www.keypedia.com/companies/natco-pharma-limited-chemical-division-chennai/c2978c98-d900-4777-9b55-7c62f09edfe0)
- [Vasudha Pharma Chem Limited](https://www.keypedia.com/companies/vasudha-pharma-chem-limited/0811b896-55df-4e1d-b8f1-b2b3bb8b88a6)
- [Kumar Organic Products Ltd.](https://www.keypedia.com/companies/kumar-organic-products-ltd/acc61a81-a684-4eb3-a4c8-d487dc0164e5)
- [ISP Sutton Laboratories](https://www.keypedia.com/companies/isp-sutton-laboratories/27126d09-6823-4e2b-8f31-d8645861af12)
- [Hisun Pharmaceutical (Nantong) Co., Ltd.](https://www.keypedia.com/companies/hisun-pharmaceutical-nantong-co-ltd/4cace88a-293f-46cb-bb3f-f89466b7412d)
- [Changzhou Sunlight Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/changzhou-sunlight-pharmaceutical-co-ltd/8dec389f-df74-4d58-8aa0-61eba8abd2eb)
- [Asahi Kasei Finechem Co., Ltd.](https://www.keypedia.com/companies/asahi-kasei-finechem-co-ltd/a6e157c7-1e20-4cf3-85d1-d9f64c58a6c0)
- [Cohance Lifesciences Limited](https://www.keypedia.com/companies/cohance-lifesciences-limited/8e48a668-3018-4c94-b846-2cdd61205a18)
- [Sichuan Qingmu Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/sichuan-qingmu-pharmaceutical-co-ltd/821a1489-2969-47a3-8321-b97728ac795a)

## Related Officers

- [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)